Livermore Lab and BridgeBio Announce Human Trials for HPC-Discovered Cancer Drug

In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics  today announced clinical trials have begun for ….